Stock NMTRQ 9 METERS BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials 9 Meters Biopharma, Inc.

Equities

NMTRQ

US6544052086

Investment Holding Companies

Delayed OTC Markets
Other stock markets
 10:00:30 2024-04-17 am EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for 9 Meters Biopharma, Inc. 0.00% 0.00%
Mar. 25 North American Morning Briefing : Tech in Focus on -2- DJ
2023 Bidding Procedure Approved for 9 Meters Biopharma, Inc. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 60.22 19.99 174.7 250.2 16.32
Enterprise Value (EV) 1 59.69 18.63 137.1 203.4 23.41
P/E ratio -2.37 x -0.69 x -1.48 x -6.47 x -0.37 x
Yield - - - - -
Capitalization / Revenue - - - - -
EV / Revenue - - - - -
EV / EBITDA -3.31 x -0.77 x -6.64 x -6.51 x -0.56 x
EV / FCF -10.8 x -3.42 x -8.84 x -10.2 x -0.63 x
FCF Yield -9.23% -29.3% -11.3% -9.79% -158%
Price to Book -16.5 x -2.29 x 5.47 x 6.07 x 6.84 x
Nbr of stocks (in thousands) 1,304 1,794 10,170 12,783 12,955
Reference price 2 46.20 11.14 17.18 19.57 1.260
Announcement Date 3/18/19 3/20/20 3/22/21 3/23/22 3/28/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - - - - -
EBITDA 1 -11.16 -18.05 -24.26 -20.63 -31.25 -42.01
EBIT 1 -11.17 -18.07 -24.28 -20.65 -31.26 -42.02
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -11.61 -24.16 -27.05 -61.5 -36.78 -43.77
Net income 1 -11.61 -24.16 -27.05 -61.5 -36.78 -43.77
Net margin - - - - - -
EPS 2 -7.358 -19.52 -16.23 -11.64 -3.026 -3.378
Free Cash Flow 1 -0.6136 -5.507 -5.448 -15.51 -19.91 -36.92
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/18 3/18/19 3/20/20 3/22/21 3/23/22 3/28/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales 1 - - - - - - - - - -
EBITDA - - - - - - - - - -
EBIT 1 -4.775 -5.399 -8.258 -13.54 -9.565 -11.36 -11.2 -8.716 -10.74 -12.79
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) 1 -4.963 -5.431 -8.253 -13.54 -9.555 -11.35 -11.13 -9.355 -11.93 -13.87
Net income 1 -4.963 -5.431 -8.253 -13.54 -9.555 -11.35 -11.13 -9.355 -11.93 -13.87
Net margin - - - - - - - - - -
EPS 2 -0.6000 -0.6000 -0.6000 -1.000 -0.8000 -0.8000 -0.8000 -0.7200 -0.9200 -1.020
Dividend per Share - - - - - - - - - -
Announcement Date 3/22/21 5/13/21 8/12/21 11/15/21 3/23/22 5/16/22 8/15/22 11/8/22 3/28/23 5/15/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 8.22 - - - - 7.08
Net Cash position 1 - 0.53 1.37 37.6 46.8 -
Leverage (Debt/EBITDA) -0.7362 x - - - - -0.1686 x
Free Cash Flow 1 -0.61 -5.51 -5.45 -15.5 -19.9 -36.9
ROE (net income / shareholders' equity) 124% 305% 408% -546% -99.7% -199%
ROA (Net income/ Total Assets) -1,113% -311% -258% -58.1% -43.7% -63%
Assets 1 1.043 7.758 10.47 105.9 84.09 69.43
Book Value Per Share 2 -0.3900 -2.810 -4.870 3.140 3.220 0.1800
Cash Flow per Share 2 0.0100 4.390 2.330 3.700 3.640 0.9700
Capex 1 0.04 0.01 0.01 0 0.01 0
Capex / Sales - - - - - -
Announcement Date 3/29/18 3/18/19 3/20/20 3/22/21 3/23/22 3/28/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Shell Companies

1st Jan change Capi.
9 METERS BIOPHARMA, INC. Stock 9 Meters Biopharma, Inc.
0.00% 14
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+164.76% 5.68B
SCREAMING EAGLE ACQUISITION CORP. Stock Screaming Eagle Acquisition Corp.
+1.65% 1.01B
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.10% 982M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 872M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+25.02% 819M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.72% 663M
E7 GROUP Stock E7 Group
+1.80% 610M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
ALTC ACQUISITION CORP. Stock AltC Acquisition Corp.
+35.42% 552M
Shell Companies
  1. Stock Market
  2. Equities
  3. NMTRQ Stock
  4. Financials 9 Meters Biopharma, Inc.